|
|
COMMERCIALIZATION OF A SOFTWARE PLATFORM TO INCREASE THE EFFICIENCY OF HUMAN CLINICAL TRIALS USING PATIENT-LEVEL MACHINE LEARNING MODELS |
| 5R44TR002047-03 |
ENNIST, DAVID L |
NCATS |
2019 |
|
|
RESISTANCE AND VULNERABILITY FOR ALZHEIMER'S AND RELATED PATHOLOGIES |
| 1R56AG058732-01A1 |
MCMILLAN, COREY T |
NIA |
2019 |
|
|
GENETIC ETIOLOGY OF AMYOTROPHIC LATERAL SCLEROSIS |
| 1ZIAAG000933-12 |
TRAYNOR, BRYAN |
NIA |
2019 |
|
|
GENETIC ETIOLOGY OF FRONTO-TEMPORAL DEMENTIA, A DEMENTIA RELATED TO ALZHEIMERS DISEASE |
| 1ZIAAG000934-11 |
TRAYNOR, BRYAN |
NIA |
2019 |
|
|
VALIDATION OF ANTIBODY REAGENTS FOR 15 HIGH PRIORITY AMP-AD TARGETS |
| 3RF1AG057443-01S3 |
MANGRAVITE, LARA M |
NIA |
2019 |
|
|
DECONSTRUCTING AND CHALLENGING TDP-43 PROTEINOPATHIES: FROM FTLD/ALS TO ALZHEIMER'S DISEASE |
| 5R01AG059871-02 |
RINCON-LIMAS, DIEGO E |
NIA |
2019 |
|
|
AMPLIDEX DEEPNET, A NEW PARADIGM FOR DEEP LEARNING ANALYTICAL TOOLS IN THE MOLECULAR DIAGNOSTIC SPACE |
| 1R43GM128498-01A1 |
LARSON, JESSICA LYNN |
NIGMS |
2019 |
|
|
PROGRAMMING HUMAN CHAPERONE SYSTEMS AGAINST NEURODEGENERATIVE DISEASE |
| 1F32NS108598-01A1 |
BARBIERI, EDWARD |
NINDS |
2019 |
|
|
NOVEL PATHWAYS IN C9ORF72-ASSOCIATED ALS AND DEMENTIA |
| 1K08NS104270-01A1 |
MORDES, DANIEL ADAM |
NINDS |
2019 |
|
|
2019 AMYOTROPHIC LATERAL SCLEROSIS (ALS) & RELATED MOTOR NEURON DISEASES GRC/GRS |
| 1R13NS111911-01 |
SATTLER, RITA |
NINDS |
2019 |
